A Study to Assess the Mass Balance of [14C] ABBV-552 in Healthy Male Participants Following Single Oral Dose Administration

Study Identifier
M24-416
CT.gov Identifier
NCT06278766
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Healthy Volunteer
    • Study Drug
  • ABBV-552
    • Phase
    Phase 1
    Sex
    Male
    Age
    18 - 55 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    \- Male volunteers in general good health at Screening.
    Exclusion Criteria:
    \- Considering fathering a child or donating sperm during the study and for 100 days after study drug administration.

    Protocol Summary

    The purpose of this study is to evaluate mass balance, pharmacokinetics and safety of \[14C\] ABBV-552 in healthy, male volunteers following administration of a single oral dose.

    Study Locations

    Location
    Status
    Location
    Fortrea Clinical Research Unit Inc /ID# 262684
    Madison, Wisconsin, United States, 53704
    Status
    Not applicable